• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2/COVID-19:病毒基因组学、流行病学、疫苗和治疗干预措施。

SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions.

机构信息

College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.

The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

出版信息

Viruses. 2020 May 10;12(5):526. doi: 10.3390/v12050526.

DOI:10.3390/v12050526
PMID:32397688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7290442/
Abstract

The COVID-19 pandemic is due to infection caused by the novel SARS-CoV-2 virus that impacts the lower respiratory tract. The spectrum of symptoms ranges from asymptomatic infections to mild respiratory symptoms to the lethal form of COVID-19 which is associated with severe pneumonia, acute respiratory distress, and fatality. To address this global crisis, up-to-date information on viral genomics and transcriptomics is crucial for understanding the origins and global dispersion of the virus, providing insights into viral pathogenicity, transmission, and epidemiology, and enabling strategies for therapeutic interventions, drug discovery, and vaccine development. Therefore, this review provides a comprehensive overview of COVID-19 epidemiology, genomic etiology, findings from recent transcriptomic map analysis, viral-human protein interactions, molecular diagnostics, and the current status of vaccine and novel therapeutic intervention development. Moreover, we provide an extensive list of resources that will help the scientific community access numerous types of databases related to SARS-CoV-2 OMICs and approaches to therapeutics related to COVID-19 treatment.

摘要

新型冠状病毒肺炎(COVID-19)是由新型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染引起的累及下呼吸道的疾病。其症状谱从无症状感染到轻微呼吸道症状,再到与严重肺炎、急性呼吸窘迫和死亡相关的 COVID-19 致死形式。为应对这一全球危机,及时了解病毒基因组学和转录组学信息对于了解病毒的起源和全球传播、深入认识病毒的致病性、传播和流行病学,以及制定治疗干预、药物发现和疫苗开发策略至关重要。因此,本综述全面概述了 COVID-19 的流行病学、基因组病因、近期转录组图谱分析结果、病毒-人类蛋白相互作用、分子诊断以及疫苗和新型治疗干预措施的开发现状。此外,我们还提供了一个广泛的资源列表,帮助科学界访问与 SARS-CoV-2 组学和 COVID-19 治疗相关的治疗方法相关的多种类型数据库。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ca/7290442/09d482262e4c/viruses-12-00526-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ca/7290442/09d482262e4c/viruses-12-00526-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ca/7290442/09d482262e4c/viruses-12-00526-g001.jpg

相似文献

1
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions.SARS-CoV-2/COVID-19:病毒基因组学、流行病学、疫苗和治疗干预措施。
Viruses. 2020 May 10;12(5):526. doi: 10.3390/v12050526.
2
Genetic characterization of SARS-CoV-2 & implications for epidemiology, diagnostics & vaccines in India.新型冠状病毒(SARS-CoV-2)的基因特征及其对印度流行病学、诊断和疫苗的影响。
Indian J Med Res. 2020;152(1 & 2):12-15. doi: 10.4103/ijmr.IJMR_3667_20.
3
COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics.2019冠状病毒病大流行:流行病学、发病机制、诊断以及潜在疫苗和治疗方法概述
Ther Deliv. 2020 Apr;11(4):245-268. doi: 10.4155/tde-2020-0035. Epub 2020 May 12.
4
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).新型冠状病毒病 2019(COVID-19)的流行病学、诊断、治疗和疫苗的现状。
J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324. doi: 10.4014/jmb.2003.03011.
5
SnapShot: COVID-19.速览:COVID-19。
Cell. 2020 May 14;181(4):954-954.e1. doi: 10.1016/j.cell.2020.04.013. Epub 2020 Apr 30.
6
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
7
COVID-19 Vaccine: A comprehensive status report.新型冠状病毒肺炎疫苗:全面现状报告。
Virus Res. 2020 Oct 15;288:198114. doi: 10.1016/j.virusres.2020.198114. Epub 2020 Aug 13.
8
Pathophysiology and treatment strategies for COVID-19.COVID-19 的病理生理学和治疗策略。
J Transl Med. 2020 Sep 15;18(1):353. doi: 10.1186/s12967-020-02520-8.
9
A Review of SARS-CoV-2 and the Ongoing Clinical Trials.SARS-CoV-2 综述及正在进行的临床试验。
Int J Mol Sci. 2020 Apr 10;21(7):2657. doi: 10.3390/ijms21072657.
10
Covid-19: a comprehensive review of a formidable foe and the road ahead.Covid-19:一个强大敌人的全面综述及未来之路。
Expert Rev Respir Med. 2020 Sep;14(9):869-879. doi: 10.1080/17476348.2020.1782198. Epub 2020 Jun 30.

引用本文的文献

1
Reinfection and post-vaccination infection by SARS-CoV-2 in nursing professionals: a prospective cohort study, Recife, 2020-2023.护理专业人员中SARS-CoV-2的再感染和接种疫苗后的感染:一项前瞻性队列研究,累西腓,2020 - 2023年
Epidemiol Serv Saude. 2025 Sep 8;34:e20240162. doi: 10.1590/S2237-96222025v34e20240162.en. eCollection 2025.
2
Impact of SARS-CoV-2 variant mutations on susceptibility to monoclonal antibodies and antiviral drugs: a non-systematic review, April 2022 to October 2024.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异突变对单克隆抗体和抗病毒药物敏感性的影响:一项非系统性综述,2022年4月至2024年10月
Euro Surveill. 2025 Mar;30(10). doi: 10.2807/1560-7917.ES.2025.30.10.2400252.
3

本文引用的文献

1
On the origin and continuing evolution of SARS-CoV-2.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的起源及持续进化
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
2
Stability of SARS-CoV-2 in different environmental conditions.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在不同环境条件下的稳定性
Lancet Microbe. 2020 May;1(1):e10. doi: 10.1016/S2666-5247(20)30003-3. Epub 2020 Apr 2.
3
Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.
Identification of Novel Genomic Variants in COVID-19 Patients Using Whole-Exome Sequencing: Exploring the Plausible Targets of Functional Genomics.
使用全外显子组测序鉴定新冠病毒肺炎患者的新型基因组变异:探索功能基因组学的潜在靶点
Biochem Genet. 2024 Nov 18. doi: 10.1007/s10528-024-10970-8.
4
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management.新型冠状病毒肺炎血栓形成:区分病理、机制、表型特征及管理
J Thromb Thrombolysis. 2025 Jan;58(1):15-49. doi: 10.1007/s11239-024-03028-4. Epub 2024 Aug 23.
5
SARS-CoV-2 RNA Detection in Wastewater and Its Effective Correlation with Clinical Data during the Outbreak of COVID-19 in Salamanca.SARS-CoV-2 RNA 在废水中的检测及其与 COVID-19 爆发期间萨拉曼卡临床数据的有效关联。
Int J Mol Sci. 2024 Jul 24;25(15):8071. doi: 10.3390/ijms25158071.
6
In Silico and In Vitro Studies of Terpenes from the Fabaceae Family Using the Phenotypic Screening Model against the SARS-CoV-2 Virus.利用针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的表型筛选模型对豆科植物萜类化合物进行的计算机模拟和体外研究。
Pharmaceutics. 2024 Jul 9;16(7):912. doi: 10.3390/pharmaceutics16070912.
7
New Virus Variant Detection Based on the Optimal Natural Metric.基于最优自然测度的新型病毒变体检测
Genes (Basel). 2024 Jul 7;15(7):891. doi: 10.3390/genes15070891.
8
Current molecular diagnostics assays for SARS-CoV-2 and emerging variants.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其新出现变体的当前分子诊断检测方法。
Methods Microbiol. 2022;50:83-121. doi: 10.1016/bs.mim.2021.10.003. Epub 2021 Dec 9.
9
A phased strengthening of laboratory capacity in the Eastern Mediterranean Region during the COVID-19 pandemic.在 COVID-19 大流行期间,东地中海区域分阶段加强实验室能力。
Influenza Other Respir Viruses. 2024 Feb 5;18(2):e13225. doi: 10.1111/irv.13225. eCollection 2024 Feb.
10
Clinical Evaluation of Direct Reverse Transcription PCR for Detection of SARS-CoV-2 Compared to Conventional RT-PCR in Patients with Positive Rapid Antigen Test Results during Circulation of Emerging Viral Variants.在新型病毒变体传播期间,对快速抗原检测结果呈阳性的患者,直接逆转录PCR检测新型冠状病毒2与传统逆转录PCR的临床评估。
Diagnostics (Basel). 2023 Dec 14;13(24):3668. doi: 10.3390/diagnostics13243668.
与 SARS-CoV-2 感染住院非重症患者病毒持续排出相关因素及洛匹那韦/利托那韦治疗的影响。
Eur Respir J. 2020 Jul 16;56(1). doi: 10.1183/13993003.00799-2020. Print 2020 Jul.
4
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
5
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.一种 SARS-CoV-2 蛋白相互作用图谱揭示了药物再利用的靶标。
Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30.
6
Association between climate variables and global transmission oF SARS-CoV-2.气候变量与 SARS-CoV-2 全球传播的关联。
Sci Total Environ. 2020 Aug 10;729:138997. doi: 10.1016/j.scitotenv.2020.138997. Epub 2020 Apr 26.
7
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.法匹拉韦治疗新型冠状病毒肺炎的实验性治疗:一项开放标签对照研究。
Engineering (Beijing). 2020 Oct;6(10):1192-1198. doi: 10.1016/j.eng.2020.03.007. Epub 2020 Mar 18.
8
The race for coronavirus vaccines: a graphical guide.新冠疫苗竞赛:图解指南
Nature. 2020 Apr;580(7805):576-577. doi: 10.1038/d41586-020-01221-y.
9
Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough.新冠病毒的空气传播途径:为什么 2 米/6 英尺的人际距离还不够。
Int J Environ Res Public Health. 2020 Apr 23;17(8):2932. doi: 10.3390/ijerph17082932.
10
Impact of temperature on the dynamics of the COVID-19 outbreak in China.温度对中国 COVID-19 疫情动态的影响。
Sci Total Environ. 2020 Aug 1;728:138890. doi: 10.1016/j.scitotenv.2020.138890. Epub 2020 Apr 23.